Literature DB >> 15226572

Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome.

Vijaya Shaharao1, Sandip Bartakke, Mamta N Muranjan, Manisha S Bavdekar, Sandeep B Bavdekar, Vrajesh P Udani.   

Abstract

A seven-year-old boy presented with a second episode of acute transverse myelopathy. The first episode had responded dramatically to methylprednisolone. The manifestations of the second episode did not respond to methylprednisolone or IVIG. He showed persistently raised levels of antiphospholipid antibodies in the serum. Primary conditions like collagen vascular diseases, malignancy, exposure to drugs and HIV infection, which are known to be associated with the raised titers of these antibodies were ruled out clinically and by investigations. Recurrent transverse myelopathy is a rare event in childhood and reports of its association with Antiphospholipid Antibody Syndrome (APLAS) are scanty. The etiological role for these antibodies remains to be established. However, once the diagnosis is established, it may be prudent to treat the condition with agents and procedures to bring about a decrease in their titers. Long-term therapy to prevent thromboembolic complications of APLAS may also be instituted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226572     DOI: 10.1007/bf02724305

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  13 in total

Review 1.  Neurological aspects of antiphospholipid antibody syndrome.

Authors:  S R Levine; R L Brey
Journal:  Lupus       Date:  1996-10       Impact factor: 2.911

Review 2.  Significance of IgA antiphospholipid antibodies.

Authors:  W A Wilson; Z Faghiri; F Taheri; A E Gharavi
Journal:  Lupus       Date:  1998       Impact factor: 2.911

3.  Chronic recurrent transverse myelitis or multiple sclerosis.

Authors:  A Ungureán; S Pálfi; G Dibó; L Tiszlavicz; L Vécsei
Journal:  Funct Neurol       Date:  1996 Jul-Aug

4.  Recurrent acute transverse myelopathy associated with anticardiolipin antibodies.

Authors:  A Campi; M Filippi; G Comi; G Scotti
Journal:  AJNR Am J Neuroradiol       Date:  1998-04       Impact factor: 3.825

Review 5.  Antiphospholipid antibody syndrome.

Authors:  M D Lockshin
Journal:  Rheum Dis Clin North Am       Date:  1994-02       Impact factor: 2.670

6.  Refractory hiccough heralding transverse myelitis in the primary antiphospholipid syndrome.

Authors:  G J Ruiz-Argüelles; J Guzmán-Ramos; J Flores-Flores; J Garay-Martínez
Journal:  Lupus       Date:  1998       Impact factor: 2.911

7.  Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier.

Authors:  M Matsui; R Kakigi; S Watanabe; Y Kuroda
Journal:  J Neurol Sci       Date:  1996-08       Impact factor: 3.181

8.  Spinal cord infarction associated with primary antiphospholipid syndrome in a young child. Case report.

Authors:  M Hasegawa; J Yamashita; T Yamashima; K Ikeda; Y Fujishima; M Yamazaki
Journal:  J Neurosurg       Date:  1993-09       Impact factor: 5.115

9.  Recurrent transverse myelitis associated with collagen disease.

Authors:  M Yamamoto
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

10.  Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome.

Authors:  V Schantz; L L Oestergaard; P Junker
Journal:  J Rheumatol       Date:  1998-07       Impact factor: 4.666

View more
  4 in total

Review 1.  Lupoid sclerosis.

Authors:  Briele Keiserman; Luiz Fernando Garcias da Silva; Mauro W Keiserman; Carlos Alberto von Mühlen; Henrique Luiz Staub
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

Review 2.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 3.  Demyelination in rheumatic diseases.

Authors:  A Theodoridou; L Settas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 4.  The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome.

Authors:  Chris Wincup; Yiannis Ioannou
Journal:  Front Pediatr       Date:  2018-11-27       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.